Leap Therapeutics (LPTX) Earnings Date & Reports

Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

LPTX is expected to report earnings to fall 72.50% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports

Q2'23

Est.

$-0.09

Q1'23

Missed

by $0.23

Q4'22

Est.

$-0.11

Q3'22

Missed

by $0.01

Q2'22

Missed

by $0.05

The last earnings report on May 15 showed earnings per share of -31 cents, missing the estimate of -8 cents. With 523.14K shares outstanding, the current market capitalization sits at 12.97M.

View a ticker or compare two or three

Compare

LPTX